Surnames and citation indexes

Biji T. Kurien of the Oklahoma Medical Research Foundation writes (Nature 453; 450; 2008):

The Correspondence ‘Give south Indian authors their true names’ (Nature 452, 530; 2008) and earlier News Feature ‘Identity crisis’ (Nature 451, 766–767; 2008) are highly relevant to calculations of PubMed citations and h-index (the number n of a researcher’s papers that have received at least n citations).

For example, I used to use the south Indian form of my name: T. Biji Kurien, with Biji being my personal name. I have seven publications cited incorrectly in PubMed as being by ‘Kurien, T. B.’, ‘Bijikurien, T.’ or ‘Kurien, B.’. Four of these entries were cited often enough to be counted towards my h-index computation. As I had by then changed my name to conform with Western style, these publications unfortunately do not appear in the Web of Science or PubMed under my current name format. Consequently, my h-index ranking has fallen by 25% .

It is of paramount importance to adhere to a consistent name pattern right from the start, in order to maintain a correct list of publications in the public databases as well as the right h-index rankings.

Prabhu B. Patil, of the Centre for Cellular and Molecular Biology, Hyderabad, writes in the same issue of Nature (453, 450; 2008):

The Correspondence ‘Give south Indian authors their true names’ (Nature 452, 530; 2008), incorrectly states that people from the south do not traditionally have surnames.

I am from southern India and have a proper surname — as do all the families in my region. Besides Patil, surnames such as Naidu, Reddy, Rao and Gouda are common in the different states of southern India. One of the authors of the Correspondence has the surname Kutty.

Surnames have widely fallen into disuse because our fathers and forefathers avoided using them to prevent discrimination on grounds of caste.

It doesn’t make sense in this case to use only an author’s first name in scientific publications and to devise a special system to accommodate a different naming format. Instead, editors should encourage these authors to revive the use of their surnames.

Comments are welcome here and at Indigenus, the blog of Nature India.

A second take on ‘ghost’ authorship

Nature Biotechnology‘s May Editorial (26, 476; 2008) adds its perspective to previous discussion in Nature, Spoonful of Medicine (the blog of Nature Medicine) and at Nature Network about ’ghost authors’ on clinical research papers from Merck. According to Nature Biotechnology, papers from the pharmaceutical industry are being unfairly stigmatized because of one company’s past poor publishing practices. Nature Biotechnology welcomes some recommendations made in an Editorial about the affair in the Journal of the American Medical Association (JAMA) (299, 1833–1835; 2008), such as conflict of interest and ‘author contribution’ statements, but goes on to add: "the JAMA editorial then goes too far, leaping on the findings to make recommendations that are unwarranted, not to say discriminatory, against the body corporate. In recommendation 4, for example, the editors imply that any research associated with “industry” is potentially tainted. In essence, the editorial calls for journal editors to take into account all financial support and financial relationships when deciding whether to publish a manuscript at all." After providing additional examples, the Nature Biotechnology Editorial concludes:

“Ghostwriting and guest authorship run contrary to the Corinthian spirit of scientific publishing. Although that spirit may have disappeared since the days when science was the exclusive province of the enthusiastic and moneyed amateur, companies that use ghostwriters and rubber-stamp experts as authors of their papers reinforce the impression that industry’s only interest in publishing is to dress up marketing as science. But the editors of JAMA and other journals would do well to focus on content, not process. JAMA‘s attack casts a cloud over the entire industry. Stigmatizing any paper that comes from the private sector on the basis of an analysis of one company’s poor publishing practices over five years ago is not only unjustified, it is discrimination pure and simple.”

Ghost authorship of research articles

The eternal question of authorship is in the frame in a News story in the current issue of Nature (452, 791; 2008), in which it is reported that thousands of of documents relating to Merck’s withdrawn painkiller rofecoxib (Vioxx) were were reviewed by medical researchers, and seem to show Merck’s extensive involvement in ghost-writing and ‘guest authorship’ of research and review papers. The results of the analysis are published by J. Ross et al. in the Journal of the American Medical Association (299, 1800–1812; 2008).

By omitting the names — or downgrading the involvement — of drug-industry writers, and adding the names of academics who were not substantially involved in a paper, the industry’s role in research may be concealed. And doctors may be misled over the independence of the work. For example, one of the Merck-held documents lists a number of clinical trials in which a Merck employee is to be author of the first draft of a manuscript. However, when these trials were published, in 16 of 20 of the articles an external academic is listed as first author. Merck denies these allegations.

See also Spoonful of Medicine, the blog of Nature Medicine.

There is further discussion of the JAMA article, and the implications for authorship credit, at Nature Network.

Publishing models and publication statistics

Juan-Carlos Lopez discusses the publication process from the authors’ perspective in a couple of posts at Spoonful of Medicine, the blog of Nature Medicine. First, he shares some data to show that the Nature journals are not biased in favour of authors based in the United States. The data shown are the ratio of submitted to published papers as a function of country. Take a look.

In a subsequent post, Juan-Carlos describes a talk he gave recently in Madrid, at which he showed these data (and received some puzzling feedback), and also was asked questions about open-access publishing. He writes: “It was fascinating to see how difficult it was for some people to understand that scientific publishing costs money, and that there are different models to recover your costs — the author-pays model, the subscription model, and everything in between …… as there are different models, publishing groups ought to choose the model that works best for each of them. In our case, the subscription-based model is the only one that seems viable for the time being. How difficult is it to get this point?”

There has been some discussion related to this topic over at Nature Network in the past week, summarized here at the blog Gobbledygook. Part of this discussion involves the latest NIH (US National Institutes of Health) policy on self-archiving of research that it has funded, requiring deposition of the author’s version into the PubMedCentral database 12 months after the journal’s publication date. For authors who aren’t sure how this affects them when submitting to Nature journals, the new NIH policy is consistent with Nature Publishing Group’s existing policy, which states: “When a manuscript is accepted for publication in an NPG journal, authors are encouraged to submit the author’s version of the accepted paper (the unedited manuscript) to PubMedCentral or other appropriate funding body’s archive, for public release six months after publication. In addition, authors are encouraged to archive this version of the manuscript in their institution’s repositories and, if they wish, on their personal websites, also six months after the original publication.”

A multitude of authors

Raf Aerts, on his Nature Network blog African Blog of Ecology, writes about the relentless increase in the number of multi-authored manuscripts. He reproduces a graph from the magazine Science Watch (November/December 2007 edition) which tracks papers grouped into four tranches of more than 50, 100, 200 and 500 authors. Between 1993 and 2003, the numbers of papers with these large numbers of authors were fairly stable, but after that time, the numbers in all categories increased significantly (to 2007). Raf Aerts writes:

“But then came the cracker: in 2000 there was a report with 918 authors, and the current record holder is physics paper published in 2006… with 2512 authors. Imagine all these authors track-changing the manuscript!”

At Nature, and many other journals, the editors ask one author to coordinate revisions and changes between all coauthors, and convey those to the journal on behalf of all of them. The challenge for the poor corresponding author must be quite significant on occasion.

Why do papers need so many authors? Modern, “big” science means that a paper can take years to gestate, involving researchers at many centres, international facilities (for expensive equipment, for example), and complex software. Martin Fenner, in a comment to Raf Aert’s post, writes: “In my last published paper I have 82 coauthors, my personal record. The paper is the result of a consensus conference on the management of testicular cancer.”

The papers tracked by Science Watch do not cover the “ten-author” paper in which a couple of professors might use their seniority muscle to add their names to an author list even though they made no contribution to the intellectual or physical effort of creating the paper. Is this type of paper making more of a mockery of the concept of “authorship” than the several-hundred author collaboration? How else would these researchers receive deserved credit for their work?

The Nature journals appreciate the problems, but wish authors to be transparent with their readers — as we do not want to support the practice of honorary authorship, while being sympathetic to genuine collaborations. We encourage coauthors of a paper to specify their contributions to the work, in a statement in the acknowledgements. Our policies, as well as (free-access) editorials in our journals on this topic, are gathered at the Author and Reviewers’ website; and our discussions of authorship on Nautilus are gathered under the tag “authorship”, which you can see listed by clicking on this link. We welcome your views, which can be made online as a comment to any of these posts.

Due credit for Asian authors

Chinese authors are publishing more and more papers, but are they receiving due credit and recognition for their work? Not if their names get confused along the way. Jane Qiu investigates these, and other questions, in a Nature news feature in the current issue of the journal (Nature 451, 766-767; 2008). The article covers the huge problem of how to distinguish between Asian researchers, given the vast numbers of people sharing relatively few surnames. The problem is particularly challenging in the publishing sphere, not only in identifying an author correctly in citation databases and other indeces, but for editors in choosing appropriate peer-reviewers. Asian researchers suffer in being hampered from full participation in the international scientific community, for example they are less likely to be invited to contribute to conferences, to be successful in grant applications or to win awards.

The news feature provides a clear overview of these issues, and more, from a range of perspectives. Some journals have begun to provide author names in original (not Latin) characters, and there are various initiatives to provide unique author identifiers. At this stage, however, there is no consensus as to the best way to proceed: there are problems of technical compatibility between publishing, database and indexing systems, of agreement on universal standards, and other challenges, such as the high mobility of scientists, making it difficult to track the author of several publications.

Nature Network has a forum “”https://network.nature.com/forums/nnano/939">What’s in an Asian name?“, in which several Asian and other researchers provide their perspective of this challenging issue for publishers and database curators. ”https://blogs.nature.com/nautilus/2006/12/web_visibility.html">A Nautilus post last year highlighted the efforts of the Human Frontiers Program to help Japanese and other Asian scientists to improve their international visibility.

Nature Materials editorial on authorship policy

Nature Materials gets to grips with the issue of authorship this month, in a freely available Editorial (Nature Materials 7, 91; 2008) about international guidelines that define authorship as “limited to those who have made a significant scientific contribution to the concept, design, execution, or interpretation of the research study”. This definition, used by many journals in their author guidelines, becomes imprecise in some circumstances, as identified in the Nature Materials editorial:

“A classic example is the case in which an experimental facility has been used to obtain some of the data. Without the work of scientists employed to run that facility those results could not be obtained. But is their contribution to the specific work enough to warrant authorship, or would acknowledgements be more appropriate? What about the director of the facility? Should the contribution of technicians warrant authorship in general? What about collaborators that helped obtain funding that was used for the work? And what about reviewers, who in some cases substantially help improve a paper, but whose contribution is mainly editorial?” The Editorial points out the difficulties in implementing clear-cut rules, but urges institutions not only to clarify and unify codes of conduct, but also to ensure that the scientists they employ and/or fund appreciate their importance.

It is the policy of the Nature journals to encourage co-authors of papers to specify their individual contributions. Full details are provided at our authors’ and reviewers’ website.

The full-text of the Nature Materials Editorial can be read here.

The single author as endangered species

“Any issue of Nature today has nearly the same number of Articles and Letters as one from 1950, but about four times as many authors. The lone author has all but disappeared. In most fields outside mathematics, fewer and fewer people know enough to work and write alone. If they could, and could spare the time and effort to do so, their funding agencies and home institutions would not permit it.” So writes Mott Greene of the University of Puget Sound in his recent (single-author, naturally) Nature essay “The demise of the lone author” (Nature 450, 1165; 2007).

Professor Greene goes on to discuss how this practice is affecting, and will affect, the system of awarding credit for work done, predicting that "in those fields where multiple authorship endangers the author credit system, we shall soon see institutionally initiated restriction on the number of authors. Paradoxically, this is likely to be endorsed by all parties as preferable to cinema-style specification of who actually did what. Most will prefer full credit for a few papers to little or no credit for many, considering where it matters most: university committees in charge of tenure, promotion and salary increments based on scholarly production. Given Nature’s role in determining, as well as chronicling, how science is reported (see Nature 450, 1; 2007), interested parties could watch these pages to see whether a trend towards more restricted authorship is emerging."

Nature‘s policy on author contribution statements is here, and was introduced in an Editorial here.

Professor Greene’s article is also available on the beautiful website that celebrates the history of the journal Nature.

Successful collaborations and their authorship

Ai Lin Chun, one of the editors of Nature Nanotechnology, writes about the column in the journal Top Down Bottom Up (example at this link), which highlights the multidisciplinary nature of nanoscience and nanotechnology by going “behind the scenes” to explore how collaborations occur and work together. Collaborations could be between two or more different disciplines (for example, physical scientists and biomedical researchers) or between academic departments and industrial researchers. The name of the section is intended to suggest how researchers with different expertise come at a problem from different directions.

If you have an interesting collaboration, please drop Ai Lin a line at her Nature Nanotechnology network group — and she might pick your collaboration to highlight in the journal.

Authors’ one-page summaries

Michael Kenward starts a debate in Nature Network’s science writers’ group called Science experiments in accessibility, in which he highlights the journal Science‘s trial project of starting each Research Article with a one-page author’s summary. Michael sees two benefits for science writers: one, to help authors to produce accessible summaries; and another to use the summaries to write more easily and confidently about the research.

Following this post is an online discusssion about the benefits to the reader of different types of summary which you may find stimulating, and to which you are welcome to contribute, or comment here. Typical summaries provided by journals range from News and Views-style editorials (articles by independent scientists in the field about a new finding), to short author summaries, to “making the paper” (interviews with an author featured on Nature‘s author page in the journal every week), to “inside the paper” (editors’ accounts of how the paper evolved from submission to acceptance during the peer-review process) to one-paragraph editors’ summaries, to science journalism, to blog posts, to podcasts. What kind of reader finds what kind of summary most useful? Would authors welcome the additional task of writing one-page summaries?